A population model of prostate cancer incidence
- 5 January 2006
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 25 (16) , 2846-2866
Abstract
Introduction of screening for prostate cancer using the prostate-specific antigen (PSA) marker of the disease led to remarkable dynamics of the incidence of the disease observed in the last two decades. A statistical model is used to provide a link between dissemination of PSA and the observed transient population responses. The model is used to estimate lead time, overdiagnosis and other relevant characteristics of prostate cancer screening. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI: Journal of the National Cancer Institute, 2003
- Thin Plate Regression SplinesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2003
- Statistical Models for Screening: Planning Public Health Programs2002
- Optimal schedules of cancer surveillance and tumor size at detectionMathematical and Computer Modelling, 2001
- Trends and Patterns of Prostate Cancer: What Do They Suggest?Epidemiologic Reviews, 2001
- Planning clinical trials to evaluate early detection programmesBiometrika, 1997
- Frailty models for survival dataLifetime Data Analysis, 1995
- Two‐Event Model for Carcinogenesis: Biological, Mathematical, and Statistical ConsiderationsRisk Analysis, 1990
- Multiplicative Models and Cohort AnalysisJournal of the American Statistical Association, 1983
- On the theory of screening for chronic diseasesBiometrika, 1969